Not medical advice. BPC-157 is sold for research. This guide does not recommend dosing, diagnosis, or therapy.
BPC-157 is one of the most written-about peptides in tissue-repair research. Scientists study it for how it may influence blood-flow signals, cell migration into damaged areas, and cross-talk between the gut and other tissues in animal models.
One-paragraph overview from our research datasheet—still scientific, but faster to read than the full mechanism list below.
BPC-157 pentadecapeptide from gastric juice accelerates multi-tissue healing via VEGFR2-eNOS, FAK-paxillin, and growth hormone receptor upregulation pathways.
Many readers want context before diving into pathways. The list below summarises what researchers and reviewers discuss—cells, animals, and (for some drug-class molecules) formal clinical trials. It is not a promise of results for any individual.
“Reported” means described in the literature, not recommended for personal use. Our peptides are for laboratory research only.
Compounds in this family are frequently studied in models of tissue injury, wound closure, and how cells reorganise after damage. Research looks at cell movement, blood-vessel support, and inflammatory balance -not at replacing medical care.
Below are mechanistic bullet points as they appear in our product reference material -useful for researchers comparing pathways. They are not simplified health claims.
Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. ~5% degradation per year refrigerated. - see our storage guide for best practices on temperature, light, and shelf life.
Typical research dosing discussion (literature-style): 200-500 μg per day · Once or twice daily, subcutaneous or intramuscular injection · IV t½ ~ 5 min; IM t½ < 30 min with linear PK in rats and dogs. IM Tmax ~6-9 min. IM bioavailability 14-19% (rat), 45-51% (dog). Stable in gastric juice >24 hrs. Metabolized via hepatic cytochrome P450; excreted renally and via bile. No human PK data formally published.
For preparation, follow the step-by-step reconstitution guide and use the reconstitution calculator to confirm draw volumes. Review subcutaneous injection basics for technique, and always verify batch purity by reading the COA.
What is BPC-157 in plain language?
BPC-157 is a research peptide we catalogue under “Healing / Recovery.” This article explains how scientists discuss it in published literature and what study types usually appear—not as a consumer product claim.
Does this page give medical advice or dosing instructions for BPC-157?
No. Content is for laboratory and research literacy only. It does not diagnose, treat, or prevent disease, and is not a dosing guide.
Where can I see purity, variants, and pricing for BPC-157?
Use the “View product” button to open the canonical shop listing for BPC-157, where specifications and research SKU details are shown.
What about online case reports, before-and-after stories, or forum “logs” for BPC-157?
Those sources are not peer-reviewed evidence. This guide focuses on preclinical literature and, where relevant, formal clinical trial programmes for drug-class molecules. Anecdotes may be interesting culturally; they are not a safe basis for dosing or medical decisions.
Open the shop listing for variants, purity notes, and research SKU details.
View productAlso known as: Body Protection Compound-157, BPC-15, PL 14736, PLD-116, Bepecin, Gastric Pentadecapeptide, PL-10, Stable Gastric Pentadecapeptide